You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Active, not recruiting
Has Results
  • Sarcoma, Alveolar Soft Part
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-11
Mar 11, 2022
N
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Active, not recruiting
  • Sarcoma, Alveolar Soft Part
  • Santa Monica, California
  • +1 more
2022-04-07
Apr 7, 2022
J
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Active, not recruiting
Has Results
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
2021-10-29
Oct 29, 2021
D
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma - 2020
Completed
  • Sarcoma, Clear Cell
  • +3 more
  • GVAX
  • Boston, Massachusetts
  • +1 more
2021-03-02
Mar 2, 2021
G
Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)
Recruiting
  • Alveolar Soft Part Sarcoma
  • GB226
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
2021-03-02
Mar 2, 2021
M
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
Active, not recruiting
  • Sarcoma
  • +10 more
  • Hypofractionated radiotherapy
  • Hyperthermia
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
2021-01-27
Jan 27, 2021
M
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma - 2020
Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
2020-11-24
Nov 24, 2020
A
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +23 more
2021-11-24
Nov 24, 2021
O
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma - 2019
Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
2021-09-23
Sep 23, 2021
I
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +11 more
2022-02-11
Feb 11, 2022
N
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Active, not recruiting
  • Advanced Solid Tumors
  • +2 more
  • New York, New York
  • +11 more
2022-01-10
Jan 10, 2022
M
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Recruiting
  • Sarcoma
  • +3 more
  • Isolated Limb Infusion
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-09-08
Sep 8, 2021
N
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
Recruiting
  • Metastatic Alveolar Soft Part Sarcoma
  • Unresectable Alveolar Soft Part Sarcoma
  • Phoenix, Arizona
  • +42 more
2022-02-08
Feb 8, 2022
E
CREATE: Cross-tumoral Phase 2 With Crizotinib
Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
2020-12-24
Dec 24, 2020
I
A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
Unknown status
  • Alveolar Soft-part Sarcoma
  • Brisbane, Australia
  • +10 more
2019-01-22
Jan 22, 2019
S
Trial of Dasatinib in Advanced Sarcomas - 2017
Completed
Has Results
  • Rhabdomyosarcoma
  • +9 more
  • Little Rock, Arkansas
  • +19 more
2018-10-23
Oct 23, 2018
N
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +31 more
  • Birmingham, Alabama
  • +142 more
2022-01-25
Jan 25, 2022
N
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma - 2015
Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +34 more
  • Gamma-Secretase Inhibitor RO4929097
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2018-07-16
Jul 16, 2018
A
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas - 2011
Completed
  • Chondrosarcomas
  • +2 more
  • (no location specified)
2018-03-06
Mar 6, 2018
C
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Active, not recruiting
Has Results
  • Adult Alveolar Soft-part Sarcoma
  • +28 more
  • doxorubicin hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +186 more
2021-08-17
Aug 17, 2021
S
Pazopanib for Metastatic Alveolar Soft Part Sarcoma - 2017
Terminated
  • Metastatic Alveolar Soft Part Sarcoma
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2017-11-03
Nov 3, 2017
G
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Recruiting
  • Sarcoma,Soft Tissue
  • Barcelona, Spain
  • +5 more
2021-11-16
Nov 16, 2021
N
Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research
Completed
  • Alveolar Soft Part Sarcoma
  • Sarcoma
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    2017-06-30
    Jun 30, 2017
    M
    Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
    Active, not recruiting
    • Soft Tissue Sarcoma, Adult
    • Soft Tissue Sarcoma, Child
    • Charlotte, North Carolina
      Levine Cancer Institute
    2021-12-14
    Dec 14, 2021
    H
    Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule - 2021
    Completed
    • Soft Tissue Sarcomas
    • Anlotinib Hydrochloride
    • Zhengzhou, Henan, China
      Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer
    2022-03-14
    Mar 14, 2022